Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577538 · ClinicalTrials.gov registry record
Prevalence of Lymphoma in IBD
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 7
- Enrollment target
NCT00577538 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 7 participants.
The verdict
NCT00577538 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medications used to treat IBD (especially immunosuppressives - Azathioprine or 6-MP - and anti-TNF alpha agents) have been associated with increased risk of lymphoma. We plan to study the association between IBD and lymphoma in a large, mixed, community based and referral population from the IBD database at Indiana University.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577538
The ClinicalTrials.gov registry entry for NCT00577538 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00577538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577538 about?
NCT00577538 is a clinical study titled "Prevalence of Lymphoma in IBD". Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medic...
What is the current status of trial NCT00577538?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2006-04. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00577538?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.